ECAT Calls on TB Alliance to Withdraw Patent Applications on Pretomanid and Launches Signature Campaign for Open Letter
On World Tuberculosis Day, the Eurasian Community for Access to Treatment (ECAT) has issued an official letter to the TB Alliance, urging the organization to withdraw its patent applications on the drug pretomanid, or to officially waive any intellectual property rights related to this essential medicine used in the treatment of multidrug-resistant tuberculosis (MDR-TB).
ECAT Presents WHO with Recommendations for Updating HIV Prevention and Treatment Guidelines
The Eurasian Community for Access to Treatment (ECAT) has submitted a comprehensive set of recommendationsto the World Health Organization (WHO) for the upcoming update of the global HIV prevention and treatment guidelines. It is important to note that the previous consolidated guidelines were published in 2022.
ECAT Meeting on Expanding Access to HIV, Viral Hepatitis, and TB Treatment and Diagnosis in the EECA Region
Today, in Tbilisi, the Eurasian Community for Access to Treatment (ECAT) convened a meeting focused on expanding access to treatment and diagnosis of HIV, viral hepatitis, and tuberculosis (TB).
Meeting Minutes from the ECAT Meeting in Istanbul, May 2024
In May 2024, the Eurasian Community for Access to Treatment (ECAT) held a meeting in Istanbul focused on expanding access to tuberculosis (TB) treatment. The event was organized by ITPC EECA in collaboration with the European Coalition Against TB. The meeting minutes are available in the attachments in English.
WHO Recognizes the Need for Active Measures in the Fight Against Hepatitis D in Response to an Open Letter from Civil Society Organizations
In July 2024, on World Hepatitis Day, civil society representatives from Eastern Europe and Central Asia (EECA), India, and Thailand, along with major international organizations such as Treatment Action Group (TAG) and ITPC Global, sent an open letter to the World Health Organization (WHO) urging the creation of a working group on hepatitis D (HDV) and the development of specific
Communiqué of the Participants of the Eurasian Community for Access to Treatment Meeting
In May 2024, the “Eurasian Community for Access to Treatment” meeting took place in Istanbul, organized by ITPC EECA in collaboration with the European Coalition to Fight TB. The meeting gathered representatives of national tuberculosis programs (NTPs) from EECA countries, as well as international and non-governmental organizations.
World Hepatitis Day: Civil Society Representatives Call on WHO to Develop Guidelines for Hepatitis D Diagnosis and Treatment
Ahead of World Hepatitis Day, civil society representatives have sent a letter to the World Health Organization (WHO), urging the organization to establish a dedicated working group on hepatitis D and develop separate guidelines for its diagnosis and treatment. The English version of the letter is available in the attachment.
Global Campaigns for Access to TB Diagnosis and Treatment: ECAT Meeting in Istanbul
As part of the Eurasian Community for Access to Treatment (ECAT) meeting, held in Istanbul from May 22–24, representatives from international organizations Médecins Sans Frontières (MSF) and Treatment Action Group (TAG) presented global campaigns aimed at expanding access to tuberculosis (TB) treatment and diagnostics.
ECAT Meeting on Expanding Access to Tuberculosis Treatment in EECA Countries
Today in Istanbul, the Eurasian Community for Access to Treatment (ECAT) launched its meeting on expanding access to tuberculosis (TB) treatment, organized by ITPC EECA in collaboration with the TB Europe TB Coalition.
Survey on Preferences for Tuberculosis Diagnosis at Healthcare Facilities
We invite everyone to participate in the survey “Understanding Preferences for Tuberculosis Diagnosis at Healthcare Facilities to Support the Development of New Tests.” Please note that the survey is available only in English and will take no more than 15 minutes to complete. The goal of the survey is to collect opinions from healthcare professionals, policymakers, researchers, and affected communities